⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 2, 2025PharmaceuticalsOpen Access

Editorial: Radiolabeled Peptides in Cancer Imaging and Therapy—Emerging Isotopes

View Full Paper

Ask AI

Bookmark

Share

Key Points

Radiolabeled peptides show promise in cancer imaging and therapy, enhancing treatment precision.
The strong affinity and rapid tissue penetration may improve targeting in clinical settings.
Emerging isotopes are aiding development in molecular imaging approaches and therapeutic strategies.
This advancement could significantly impact treatment options for various cancer types.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Editorial reviews the rise of radiolabeled peptides in cancer imaging and therapy, indicating their potential in precision oncology.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Noeen Malik (2025) studied this question.

synapsesocial.com/papers/6930e8cdea1aef094cca392e https://doi.org/10.3390/ph18121836

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Radiolabeled Peptides and Antibodies in MedicineHuman Clinical Trial · 2020 · 76 citations
2α Emitter-Labeled Radiopeptides for Targeted α Therapy of Tumors2025
3Emerging PET Imaging Agents and Targeted Radioligand Therapy: A Review of Clinical Applications and Trials2025 · 14 citations
4Cutting‐edge advances in bicyclic peptide‐based radiotracers for cancer imaging and theranosticsClinical Trial · 2026 · 2 citations
5Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management2025 · 13 citations